Article info
PDFLetter
Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges
- Correspondence to Dr Stephanie Weibel, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wurzburg, 97080 Wurzburg, Germany; weibel_s{at}ukw.de
Citation
Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges
Publication history
- Accepted August 3, 2021
- First published August 20, 2021.
Online issue publication
May 24, 2022
Article Versions
- Previous version (24 May 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.